Back to the main directory
EarningsReview / Equity
- FQ2 25 results first take: weaker than expected by BNP Paribas Exane
- Taking share, but that doesn’t come cheap by BNP Paribas Exane
- Is it enough? by BNP Paribas Exane
- Steady As She Goes by BNP Paribas Exane
- Volvo Cars (Hold, TP: SEK23.00) - ‘Transitioning’ to further uncertainty by DnB Markets
- DOF Group (Buy, TP: NOK135.00) - Set for an eventful 2025e by DnB Markets
- Stillfront Group (Buy, TP: SEK12.00) - FCF holding up well by DnB Markets
- Scorpio Tankers (Buy, TP: USD82.00) - Undervalued cash flow potential by DnB Markets
- Pandora (Buy, TP: DKK1550.00) - Better than recognised by DnB Markets
- Lundbeck (Buy, TP: DKK56.00) - PTSD decision getting closer by DnB Markets
- ChemoMetec (Buy, TP: DKK675.00) - Growth that counts by DnB Markets
- Securitas (Buy, TP: SEK200.00) - Strength continues into 2025 by DnB Markets
- Peab (Hold, TP: SEK85.00) - Mixed Q4, but boost from one-offs by DnB Markets
- New Wave Group (Buy, TP: SEK138.00) - More promising 2025 by DnB Markets
- Boliden (Buy, TP: SEK490.00) - Rosy outlook for copper and gold by DnB Markets
- Boliden (Buy, TP: SEK490.00) - Rosy outlook for copper and gold by DnB Markets
- Model update by BNP Paribas Exane
- Q4’24 First Take: Some growth cracks, but continued margin progress by BNP Paribas Exane
- Itaú BBA on Amazon: A Quarter That Brings More Questions Than Answers by Itau
- Lower credit cost drives PAT beat by BNP Paribas Exane
- Rejlers - Reaching the next level by Danske Bank Equity Research
- Fabege - Leaving the worst behind by Danske Bank Equity Research
- Carlsberg - Relief… another round on Carlsberg! by Danske Bank Equity Research
- 4Q24 earnings beat; Initial FY ’25 guidance released by BNP Paribas Exane
- Prices, volumes, arbitrage opportunities, and implications on company profits by BNP Paribas Exane
- 4Q:24 First Look: Strong 4Q, FY25 Rev. in-line but F1Q Rev./margins weak by BNP Paribas Exane
- H125 results and 15 questions for management by BNP Paribas Exane
- IDEXpected more by BNP Paribas Exane
- Norwegian Air Shuttle (Buy, TP: NOK14.00) - January traffic statistics by DnB Markets
- Kitron (Buy, TP: NOK40.00) - Still waiting for a market recovery by DnB Markets
- Sinch (Buy, TP: SEK33.00) - Exiting a year without growth by DnB Markets
- Husqvarna (Sell, TP: SEK48.00) - Structural headwinds intensifying by DnB Markets
- Nordic Semiconductor (Buy, TP: NOK174.00) - Still appears set for a pivotal year by DnB Markets
- Swedish Orphan Biovitrum (Buy, TP: SEK365.00) - Investing for growth by DnB Markets
- Aker BP (Buy, TP: NOK280.00) - Supportive Johan Sverdrup outlook by DnB Markets
- Sampo Oyj (Buy, TP: EUR49.00) - Strong underwriting momentum by DnB Markets
- Pandox (Hold, TP: SEK215.00) - Stable results, fair valuation by DnB Markets
- Bufab (Hold, TP: SEK430.00) - Reflecting on Q4 results by DnB Markets
- GN Group (Buy, TP: DKK230.00) - Enterprise likely to return to growth by DnB Markets
- Novo Nordisk (Buy, TP: DKK1040.00) - Credibility rebuilding by DnB Markets
- The weekly navigator by DnB Markets
- FQ2 25 call feedback: reminding lack of predictability by BNP Paribas Exane
- Ralph Lauren MADE Great Again by BNP Paribas Exane
- Itaú BBA on Axtel: Strong Quarter drives FY24 Results to meet Guidance by Itau
- Inter & Co (INTR US) by HSBC
- Peab - Heading into 2025 with optimism by Danske Bank Equity Research
- Wallenstam AB - Quality at a discount by Danske Bank Equity Research
- Valuation Station: Achtung Baby by BNP Paribas Exane
- Re-assessing US risks shows consensus well underpinned by BNP Paribas Exane
- Copper performance outweighs continued drag from Diamonds by BNP Paribas Exane